None
Quote | Dyne Therapeutics Inc. (NYSE:DYN)
Last: | $ |
---|---|
Change Percent: | -2.51% |
Open: | $13.12 |
Close: | $12.81 |
High: | $13.18 |
Low: | $12.76 |
Volume: | 22,175,203 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Dyne Therapeutics Inc. (NYSE:DYN)
2024-04-23 10:29:06 ET More on Edgewise Therapeutics Edgewise Therapeutics: Behind The Massive Rally Krystal Biotech, Candel, Edgewise gain after FDA fast track tags Seeking Alpha’s Quant Rating on Edgewise Therapeutics Historical earnings data for Edg...
2024-04-20 23:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Dyne Therapeutics Inc. (NYSE:DYN)
Subject | By | Source | When |
---|---|---|---|
Share structure TSX:DNG | MWM | investorshub | 10/27/2010 1:08:55 PM |
The company began the year with a milling | MWM | investorshub | 10/14/2010 3:41:17 AM |
Next move ? | drluck | investorshub | 12/14/2009 2:00:03 AM |
Who is running this show? If I set | Rock_E_Bottom | investorshub | 01/23/2007 11:29:33 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-04-20 23:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that it has granted an induceme...
WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage muscle disease company focused on adva...